Hypothetical scenario for illustration only: You notice your edges look thinner than they did two years ago, or the crown of your hair seems to be pulling back. You wonder whether it is stress, your style choices, genetics, or something more serious. The answer matters — because traction alopecia and CCCA look similar early on but have completely different causes, trajectories, and treatments.

Why This Matters

Hair loss is disproportionately common among Black women, driven partly by styling practices, partly by genetics, and partly by conditions that mainstream dermatology has historically underprioritized in research and clinical training. Getting an accurate diagnosis early is the difference between reversible thinning and permanent scarring.

Traction Alopecia: The Styling-Related Type

Traction alopecia results from repeated, prolonged mechanical tension on the hair follicle. It is associated with hairstyles that pull — tight ponytails, high buns, locs that are too heavy, weaves sewn in too tightly, and braids installed under significant tension. Over time, the follicle is damaged, and if the traction continues, hair loss can become permanent.

The classic presentation is thinning along the frontal hairline and temples — the area most often pulled taut. Early signs include smaller hairs along the hairline, follicular papules (small bumps at follicle openings), and broken hairs. In early stages, stopping the offending style can allow full recovery. In later stages, when follicles have scarred, regrowth is not possible.

CCCA: The Scarring Type That Starts at the Crown

Central centrifugal cicatricial alopecia (CCCA) is the most common cause of scarring hair loss in Black women, according to a clinical review published in the NIH’s PubMed Central. Unlike traction alopecia, it starts at the center — the crown or midscalp — and spreads outward. “Cicatricial” means scarring: once the follicle scars, it cannot regrow hair.

CCCA was historically attributed solely to hair care practices, specifically hot combs, which led to its earlier name “hot comb alopecia.” Current evidence is more nuanced. While certain practices may contribute, genetics appear to play a significant role. A study of 14 Black South African families found a pattern suggesting autosomal dominant inheritance, and some patients had no history of traction-based styling. Associations have also been found between CCCA and type 2 diabetes and uterine fibroids, though why these conditions cluster together is not fully understood.

Two small prevalence studies found CCCA rates of 5.6% and 28% in separate samples of Black women — a wide range that reflects different study populations and suggests larger studies are urgently needed. The condition is almost certainly underdiagnosed, partly because early symptoms are subtle.

“CCCA is almost always diagnosable — but only if someone looks. Black women deserve access to dermatologists trained to examine scalps that look like theirs.”

Early Signs That Warrant Evaluation

Don’t Wait On These Signs

  • Thinning beginning at the crown or midscalp (not just the edges)
  • A visible widening of the center part
  • Burning, itching, tenderness, or scalp sensitivity — especially at the top of the head
  • Scaling, redness, or pustules on the scalp
  • Hair that seems permanently shorter in the center than the edges
  • Any frontal hairline recession in the absence of tight styling

Diagnosis and Treatment

CCCA is diagnosed by a dermatologist with a scalp biopsy — a 4mm punch taken from an actively inflamed area. Dermoscopy (a lighted magnifying exam) can guide where to biopsy. Because CCCA can look like other conditions including discoid lupus and lichen planopilaris, biopsy is important before committing to treatment.

Active inflammation phase: Treatment typically includes high-potency topical steroids, intralesional triamcinolone injections every four to six weeks for three to six months, and oral doxycycline for approximately three months to reduce inflammation. Antiseborrheic shampoos are also commonly used.

Regrowth phase: Once active inflammation is controlled, daily topical minoxidil (2% or 5%) supports regrowth in surviving follicles, with periodic maintenance injections as needed. Platelet-rich plasma has been mentioned in some reviews but lacks sufficient evidence for a standard recommendation.

For traction alopecia, the primary intervention is removing the source of tension. This may require changes to styling practices — reducing pull, varying styles, taking breaks from extensions. Minoxidil can support regrowth in early-stage cases where the follicle has not yet scarred.

Practical Steps

What You Can Do Now

  • Document your hairline over time. A photo every few months is the best way to detect slow changes the eye misses day to day.
  • Alternate tension levels in styling. Periods of lower-tension styles give the hairline and crown time to recover from prolonged pull.
  • See a dermatologist — ideally one with experience in textured hair — if you notice any crown thinning, frontal recession, or scalp symptoms. Early treatment has significantly better outcomes than late treatment.
  • Ask specifically about CCCA. Some providers unfamiliar with the condition may attribute all hair loss to styling; persistent scalp changes warrant a biopsy.

Three Questions to Ask Your Dermatologist

  • “Based on where my hair loss is located and how it looks, do I need a scalp biopsy to rule out CCCA?”
  • “Is there active inflammation right now, and if so, what treatment will address it before more follicles scar?”
  • “Are there styling changes that would reduce progression, and what affordable options would you recommend?”

The Bottom Line

Traction alopecia and CCCA are two distinct conditions with overlapping appearances but different mechanisms and treatment paths. Traction alopecia can be reversed in early stages by reducing styling tension. CCCA requires dermatologic diagnosis and active anti-inflammatory treatment to preserve remaining follicles. The best outcome in both cases depends on catching the condition early — and on having access to a provider who takes scalp health in Black women seriously.

References

  1. PMC / NIH. “Central Centrifugal Cicatricial Alopecia: Overview of Disease and Management.” 2023. pmc.ncbi.nlm.nih.gov/articles/PMC10286866 [Peer-reviewed clinical review]
  2. HMP Global Learning Network. “Hair Loss in Black Women.” 2023. hmpgloballearningnetwork.com [Clinical education article]
  3. Practical Dermatology. “Hair’s the Thing.” May 2023. practicaldermatology.com [Clinical review]
  4. Black Health. “Hair Loss in Black Women: CCCA.” blackhealth.org [Health education resource]
  5. American Academy of Dermatology. Hair Loss Patient Education. aad.org [Professional society patient education]

Black-Led Organizations & Resources

These organizations are independently operated. iBlackBeauty.com is not affiliated with them and does not receive compensation for these links.

Expert Guidance Built for You

iBlackBeauty was created by a Board-Certified Acute Care NP for Black and Latina women who are done settling for generic health advice that was never designed for their bodies.

N
Reviewed & Written by
Nellie W.K., MSN, AGACNP-BC
Board-Certified Nurse Practitioner · Metabolic & Women’s Health

Nellie W.K. is a Board-Certified Adult-Gerontology Acute Care Nurse Practitioner with 10+ years of clinical experience specializing in metabolic health and preventive care for Black and Latina women. She is the founder of iBlackBeauty.com.

Read full credentials →